MLTX

MoonLake Immunotherapeutics

Jun 02 • 04:00PM ET

17.87

-0.95 -5.05 %

Healthcare • Biotechnology • Switzerland • Small • NASD

Peers: ARQT MANE ORKA KRYS KYMR NUVL AXSM BMRN RYTM INCY

| Held by: VHT DWAS SBIO ESML PTH NUSC ONEQ OPTZ BBC FHLC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-3.87	Insider Own	14.14%	Shs Outstand	72.13M	Perf Week	-1.97%
Market Cap	1.32B	Forward P/E	-	EPS next Y	-3.64	Insider Trans	-29.74%	Shs Float	63.21M	Perf Month	6.81%
Enterprise Value	1.06B	PEG	-	EPS next Q	-0.93	Inst Own	82.12%	Short Float	8.65%	Perf Quarter	1.02%
Income	-257.08M	P/S	-	EPS this Y	-8.59%	Inst Trans	15.37%	Short Ratio	5.46	Perf Half Y	30.15%
Sales	0.00M	P/B	5.07	EPS next Y	4.96%	ROA	-56.40%	Short Interest	5.47M	Perf YTD	35.58%
Book/sh	3.52	P/C	3.68	EPS next 5Y	6.32%	ROE	-77.72%	52W High	62.75 -71.52%	Perf Year	-56.58%
Cash/sh	4.86	P/FCF	-	EPS past 3/5Y	-27.48% -256.78%	ROIC	-72.64%	52W Low	5.95 200.34%	Perf 3Y	-35.95%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.25% 5.85%	Perf 5Y	78.70%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-68.11%	Oper. Margin	-	ATR (14)	1.00	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	8.60	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	49.95	Recom	1.75
Dividend Gr. 3/5Y	- -	Current Ratio	8.60	EPS Q/Q	-54.82%	SMA20	-0.18%	Beta	1.04	Target Price	30.64
Payout	-	Debt/Eq	0.40	Sales Q/Q	-	SMA50	1.27%	Rel Volume	1.12	Prev Close	18.82
Employees	130	LT Debt/Eq	0.39	Earnings	May 10 AMC	SMA200	-14.93%	Avg Volume	1.00M	Price	17.87
IPO	Oct 20, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-9.89% -	Trades		Volume	1,119,241	Change	-5.05%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)